23 Dec 2020
by A Hill, C J Thompson, A Algethami, J P O’Neill, A McErlean, A Khojah, F Bukhari, D Smith, A Agha, M Binhussein, B Alharthi, C Flannery, M Sherlock

P05 Primary Hyperparathyroidism The Role of MIBI combined with SPECT CT

Localisation studies using technetium-labelled sestamibi scintigraphy (MIBI) facilitates selective parathyroidectomy in patients with primary hyperparathyroidism. However, the reported sensitivity of this technique varies considerably between studies. This study aims to determine the sensitivity of sestamibi SPECT/CT in localising parathyroid adenomas in primary hyperparathyroidism and to investigate the effects of biochemical and clinical parameters on this sensitivity.

Authors

A Hill

C J Thompson

A Algethami

J P O’Neill

A McErlean

A Khojah

F Bukhari

D Smith

A Agha

M Binhussein

B Alharthi

C Flannery

M Sherlock